In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

IRhythm Technologies gets $19mm in Series A money

Executive Summary

IRhythm Technologies (cardiac monitoring devices) has raised an additional $6.5mm to bring its Series A venture round to $19mm. All of the company's prior backers participated including Mohr Davidow Ventures, Synergy Life Science Partners Equity Fund, UNC Kenan-Flagler Private Equity Fund, and Stanford University, where iRhythm's technology was originally developed.
Deal Industry
  • Medical Devices
  • Medical Devices
    • Monitoring Equipment & Devices
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies